WallStSmart

Coca-Cola Femsa SAB de CV ADR (KOF)vsMondelez International Inc (MDLZ)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Coca-Cola Femsa SAB de CV ADR generates 647% more annual revenue ($296.20B vs $39.67B). MDLZ leads profitability with a 8.9% profit margin vs 8.1%. MDLZ appears more attractively valued with a PEG of 1.03. MDLZ earns a higher WallStSmart Score of 66/100 (B-).

KOF

Buy

54

out of 100

Grade: C-

Growth: 6.0Profit: 6.5Value: 5.7Quality: 5.5
Piotroski: 3/9Altman Z: 2.47

MDLZ

Strong Buy

66

out of 100

Grade: B-

Growth: 6.7Profit: 6.5Value: 4.7Quality: 4.5
Piotroski: 3/9Altman Z: 1.60
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

KOFUndervalued (+57.6%)

Margin of Safety

+57.6%

Fair Value

$265.80

Current Price

$110.53

$155.28 discount

UndervaluedFair: $265.80Overvalued
MDLZSignificantly Overvalued (-21.4%)

Margin of Safety

-21.4%

Fair Value

$50.65

Current Price

$61.44

$10.79 premium

UndervaluedFair: $50.65Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

KOF2 strengths · Avg: 8.0/10
Price/BookValuation
2.8x8/10

Reasonable price relative to book value

Free Cash FlowQuality
$8.86B8/10

Generating 8.9B in free cash flow

MDLZ4 strengths · Avg: 8.8/10
EPS GrowthGrowth
144.9%10/10

Earnings expanding 144.9% YoY

Market CapQuality
$79.59B9/10

Large-cap with strong market position

Price/BookValuation
3.0x8/10

Reasonable price relative to book value

Operating MarginProfitability
22.0%8/10

Strong operational efficiency at 22.0%

Areas to Watch

KOF3 concerns · Avg: 3.0/10
Revenue GrowthGrowth
4.7%4/10

4.7% revenue growth

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
17.752/10

Expensive relative to growth rate

MDLZ3 concerns · Avg: 3.7/10
Revenue GrowthGrowth
4.1%4/10

4.1% revenue growth

Altman Z-ScoreHealth
1.604/10

Distress zone — elevated risk

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : KOF

The strongest argument for KOF centers on Price/Book, Free Cash Flow.

Bull Case : MDLZ

The strongest argument for MDLZ centers on EPS Growth, Market Cap, Price/Book. PEG of 1.03 suggests the stock is reasonably priced for its growth.

Bear Case : KOF

The primary concerns for KOF are Revenue Growth, Piotroski F-Score, PEG Ratio.

Bear Case : MDLZ

The primary concerns for MDLZ are Revenue Growth, Altman Z-Score, Piotroski F-Score.

Key Dynamics to Monitor

KOF carries more volatility with a beta of 0.53 — expect wider price swings.

KOF is growing revenue faster at 4.7% — sustainability is the question.

KOF generates stronger free cash flow (8.9B), providing more financial flexibility.

Monitor BEVERAGES - NON-ALCOHOLIC industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MDLZ scores higher overall (66/100 vs 54/100). KOF offers better value entry with a 57.6% margin of safety. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Coca-Cola Femsa SAB de CV ADR

CONSUMER DEFENSIVE · BEVERAGES - NON-ALCOHOLIC · USA

Coca-Cola FEMSA, SAB de CV, a franchise bottler, produces, markets, sells and distributes Coca-Cola brand beverages. The company is headquartered in Mexico City, Mexico.

Visit Website →

Mondelez International Inc

CONSUMER DEFENSIVE · CONFECTIONERS · USA

Mondelez International, Inc. is an American multinational confectionery, food, holding and beverage and snack food company based in Chicago, Illinois.

Visit Website →

Want to dig deeper into these stocks?